WILY.Y Stock Overview
Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Demant A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr.22.20 |
| 52 Week High | kr.27.06 |
| 52 Week Low | kr.19.05 |
| Beta | 0.91 |
| 1 Month Change | -11.69% |
| 3 Month Change | n/a |
| 1 Year Change | 4.91% |
| 3 Year Change | -12.91% |
| 5 Year Change | 47.02% |
| Change since IPO | 144.09% |
Recent News & Updates
Recent updates
Shareholder Returns
| WILY.Y | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -0.6% | 1.4% | 1.2% |
| 1Y | 4.9% | -0.7% | 24.7% |
Return vs Industry: WILY.Y exceeded the US Medical Equipment industry which returned -0.7% over the past year.
Return vs Market: WILY.Y underperformed the US Market which returned 24.7% over the past year.
Price Volatility
| WILY.Y volatility | |
|---|---|
| WILY.Y Average Weekly Movement | 6.6% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: WILY.Y has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine WILY.Y's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1904 | 21,623 | Søren Nielsen | www.demant.com |
Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services.
Demant A/S Fundamentals Summary
| WILY.Y fundamental statistics | |
|---|---|
| Market cap | US$10.01b |
| Earnings (TTM) | US$365.70m |
| Revenue (TTM) | US$3.22b |
27.3x
P/E Ratio3.1x
P/S RatioIs WILY.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WILY.Y income statement (TTM) | |
|---|---|
| Revenue | kr.22.44b |
| Cost of Revenue | kr.5.90b |
| Gross Profit | kr.16.54b |
| Other Expenses | kr.13.99b |
| Earnings | kr.2.55b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 06, 2024
| Earnings per share (EPS) | 11.72 |
| Gross Margin | 73.72% |
| Net Profit Margin | 11.37% |
| Debt/Equity Ratio | 126.0% |
How did WILY.Y perform over the long term?
See historical performance and comparison